{"company":{"id":2067267,"name":"Pharming","domain":"pharming.com","url":"https://alion.io/company/pharming"},"section":"news","answer":"Pharming: 12 headlines on record, 8 headlines in the last 90 days.","figures":[{"label":"Headlines","value":"12"},{"label":"In 90 days","value":"8"},{"label":"Milestones","value":"0"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":12}],"news":[{"date":"2026-10-06","kind":"News","title":"Pharmaceutical Executive Daily: Fabrice Chouraqui Steps Down as CEO of Pharming PharmExec","source":"pharmexec.com","url":"https://pharmexec.com/view/daily-fabrice-chouraqui-steps-down-ceo-pharming"},{"date":"2026-10-06","kind":"News","title":"Pharming CEO Fabrice Chouraqui Steps Down Amid Strategic Disagreement with Board PharmExec","source":"pharmexec.com","url":"https://pharmexec.com/view/ceo-fabrice-chouraqui-steps-down"},{"date":"2026-09-30","kind":"News","title":"Pharming Group: Viable Contrarian Buy If Ruconest Stabilizes","source":"seekingalpha.com","url":"https://seekingalpha.com/article/4950969-pharming-group-stock-viable-contrarian-buy-if-ruconest-stabilizes"},{"date":"2026-09-29","kind":"News","title":"Pharming announces CEO transition","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/pharming-announces-ceo-transition-050000012.html"},{"date":"2026-09-29","kind":"News","title":"Pharming CEO Fabrice Chouraqui Resigns After Disagreement on Direction","source":"marketwatch.com","url":"https://marketwatch.com/story/pharming-ceo-fabrice-chouraqui-resigns-after-disagreement-on-direction-da880f04"},{"date":"2026-09-29","kind":"News","title":"Pharming Group N.V.: Pharming announces CEO transition","source":"FinanzNachrichten.de","url":"https://finanznachrichten.de/nachrichten-2026-09/69701441-pharming-group-n-v-pharming-announces-ceo-transition-399.htm"},{"date":"2026-09-25","kind":"News","title":"Pharming Group N.V.: Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja to treat children with APDS","source":"FinanzNachrichten.de","url":"https://finanznachrichten.de/nachrichten-2026-09/69680712-pharming-group-n-v-pharming-announces-u-s-fda-acceptance-and-priority-review-of-snda-for-lower-doses-of-joenja-to-treat-children-with-apds-399.htm"},{"date":"2026-09-17","kind":"News","title":"Pharming Group (PHAR) Expands Joenja's Pediatric Label. Can Growth Offset RUCONEST Weakness?","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/pharming-group-phar-expands-joenja-224444784.html"},{"date":"2024-10-14","kind":"News","title":"Where Pharming Stands With Analysts","source":"nasdaq.com","url":"https://nasdaq.com/articles/where-pharming-stands-analysts"},{"kind":"News","title":"Life sciences and healthcare","source":"vanlanschotkempen.com","url":"https://vanlanschotkempen.com/en-nl/investment-banking/corporate-finance/life-sciences-and-healthcare"},{"kind":"News","title":"RBC Capital Markets","source":"rbccm.com","url":"https://rbccm.com/en/insights/rbc-research.page"},{"kind":"News","title":"Canaccord Genuity","source":"canaccordgenuity.com","url":"https://canaccordgenuity.com/capital-markets/expertise/research-and-strategy/"}],"as_of":"2026-11-13","cite":"Pharming, News. Alion, Nov 13, 2026. https://alion.io/company/pharming/news","html_url":"https://alion.io/company/pharming/news","json_url":"https://alion.io/company/pharming/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-13T21:10:50Z"}}